THE EPITOPES OF INFLUENZA NUCLEOPROTEIN RECOGNIZED BY CYTOTOXIC LYMPHOCYTES-T CAN BE DEFINED WITH SHORT SYNTHETIC PEPTIDES

被引:1730
作者
TOWNSEND, ARM
ROTHBARD, J
GOTCH, FM
BAHADUR, G
WRAITH, D
MCMICHAEL, AJ
机构
[1] IMPERIAL CANC RES FUND,LONDON WC2,ENGLAND
[2] NATL INST MED RES,LONDON NW7 1AA,ENGLAND
关键词
D O I
10.1016/0092-8674(86)90019-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:959 / 968
页数:10
相关论文
共 43 条
[1]  
ALLEN PM, 1985, J IMMUNOL, V135, P368
[2]  
Askonas BA, 1982, BASIC APPLIED INFLUE, P159
[3]   BINDING OF IMMUNOGENIC PEPTIDES TO IA HISTOCOMPATIBILITY MOLECULES [J].
BABBITT, BP ;
ALLEN, PM ;
MATSUEDA, G ;
HABER, E ;
UNANUE, ER .
NATURE, 1985, 317 (6035) :359-361
[4]   GENE COMPOSITION OF HIGH-YIELDING INFLUENZA VACCINE STRAINS OBTAINED BY RECOMBINATION [J].
BAEZ, M ;
PALESE, P ;
KILBOURNE, ED .
JOURNAL OF INFECTIOUS DISEASES, 1980, 141 (03) :362-365
[5]  
BENACERRAF B, 1978, J IMMUNOL, V120, P1809
[6]   GENES REQUIRED FOR CYTOTOXICITY AGAINST VIRUS-INFECTED TARGET-CELLS IN K-REGION AND D-REGION OF H-2 COMPLEX [J].
BLANDEN, RV ;
DOHERTY, PC ;
DUNLOP, MBC ;
GARDNER, ID ;
ZINKERNAGEL, RM ;
DAVID, CS .
NATURE, 1975, 254 (5497) :269-270
[7]   DIFFERENT D-END-DEPENDENT ANTIGENIC DETERMINANTS ARE RECOGNIZED BY H-2-RESTRICTED CYTOTOXIC T-CELLS SPECIFIC FOR INFLUENZA AND BEBARU VIRUSES [J].
BLANDEN, RV ;
MULLBACHER, A ;
ASHMAN, RB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 150 (01) :166-173
[8]   T-CELL ANTIGENIC SITES TEND TO BE AMPHIPATHIC STRUCTURES [J].
DELISI, C ;
BERZOFSKY, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (20) :7048-7052
[9]   CHARACTERIZATION OF THE MURINE ANTIGENIC DETERMINANT, DESIGNATED L3T4A, RECOGNIZED BY MONOCLONAL-ANTIBODY GK1.5 - EXPRESSION OF L3T4A BY FUNCTIONAL T-CELL CLONES APPEARS TO CORRELATE PRIMARILY WITH CLASS II MHC ANTIGEN-REACTIVITY [J].
DIALYNAS, DP ;
WILDE, DB ;
MARRACK, P ;
PIERRES, A ;
WALL, KA ;
HAVRAN, W ;
OTTEN, G ;
LOKEN, MR ;
PIERRES, M ;
KAPPLER, J ;
FITCH, FW .
IMMUNOLOGICAL REVIEWS, 1983, 74 :29-56
[10]  
FLEISCHER B, 1985, J IMMUNOL, V135, P2800